A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

NCT00595101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: PF-03187207
DRUG: Latanoprost 0.005%
DRUG: PF-03187207 Vehicle
DRUG: Latanoprost Vehicle

Sponsor

Bausch & Lomb Incorporated